Lack of CC chemokine ligand 2 differentially affects inflammation and fibrosis according to the genetic background in a murine model of steatohepatitis

Clinical Science

Volumn 123, Issue 7, 2012, Pages 459-471

  Galastri, Sara ^a   Zamara, Elena ^b   Milani, Stefano ^a   Novo, Erica ^b   Provenzano, Angela ^a   Delogu, Wanda ^a   Vizzutti, Francesco ^a   Sutti, Salvatore ^c   Locatelli, Irene ^c   Navari, Nadia ^a   Vivoli, Elisa ^a   Caligiuri, Alessandra ^a   Pinzani, Massimo ^a   Albano, Emanuele ^c   Parola, Maurizio ^b   Marra, Fabio ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

^b UNIVERSITY OF TURIN   (Italy)

^c UNIVERSITY OF EASTERN PIEDMONT   (Italy)

Author keywords

CC chemokine ligand 2; Chemokine; Cytokine; Liver fibrosis; Non alcoholic steatohepatitis.

Indexed keywords

ALANINE AMINOTRANSFERASE; ALPHA SMOOTH MUSCLE ACTIN; CYTOKINE; DECTIN 1; INTERLEUKIN 4; MACROPHAGE GALACTOSE TYPE C TYPE LECTIN 1; MONOCYTE CHEMOTACTIC PROTEIN 1; PROCOLLAGEN C PROTEINASE; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CELL INFILTRATION; CONTROLLED STUDY; DIET; FIBROGENESIS; FIBROSIS; GENETIC ANALYSIS; IMAGE ANALYSIS; INFLAMMATION; LIVER WEIGHT; MOUSE; NONALCOHOLIC FATTY LIVER; NONHUMAN; OXIDATIVE STRESS; POLARIZATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STAINING;

ANIMALS; CHEMOKINE CCL2; COLLAGEN TYPE I; DIETARY FATS; DISEASE MODELS, ANIMAL; FATTY LIVER; HEPATIC STELLATE CELLS; LIVER CIRRHOSIS; MACROPHAGES; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, KNOCKOUT; OXIDATIVE STRESS; SPECIES SPECIFICITY; TISSUE INHIBITOR OF METALLOPROTEINASE-1; TRANSFORMING GROWTH FACTOR BETA;

EID: 84864017250     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: 10.1042/CS20110515     Document Type: Article

References (38)

1. Angulo, P. (2002) Nonalcoholic fatty liver disease. N Engl. J. Med. 346, 1221-1231
2. Marra, F., Gastaldelli, A., Svegliati Baroni, G., Tell, G. and Tiribelli, C. (2008) Molecular basis and mechanisms of progression of non-alcoholic steatohepatitis. Trends Mol. Med. 14, 72-81
3. Tilg, H. and Moschen, A. R. (2010) Evolution of inflammation in nonalcoholic fatty liver disease: the multiple parallel hits hypothesis. Hepatology 52, 1836-1846
4. Wasmuth, H. E., Tacke, F. and Trautwein, C. (2010) Chemokines in liver inflammation and fibrosis. Semin. Liver Dis. 30, 215-225
5. Deshmane, S. L., Kremlev, S., Amini, S. and Sawaya, B. E. (2009) Monocyte chemoattractant protein-1 (MCP-1): an overview. J. Interferon Cytokine Res. 29, 313-326
6. Gu, L., Tseng, S., Horner, R. M., Tam, C., Loda, M. and Rollins, B. J. (2000) Control of TH2 polarization by the chemokine monocyte chemoattractant protein-1. Nature 404, 407-411
7. - /- aortic smooth muscle cells. J. Leukocyte Biol. 75, 1079-1085
8. Marra, F., Romanelli, R. G., Giannini, C., Failli, P., Pastacaldi, S., Arrighi, M. C., Pinzani, M., Laffi, G., Montalto, P. and Gentilini, P. (1999) Monocyte chemotactic protein-1 as a chemoattractant for human hepatic stellate cells. Hepatology 29, 140-148
9. Marra, F. (2002) Chemokines in liver inflammation and fibrosis. Front. Biosci. 7, d1899-1914
10. Berres, M. L., Nellen, A. and Wasmuth, H. E. (2010) Chemokines as immune mediators of liver diseases related to the metabolic syndrome. Dig. Dis. 28, 192-196
11. Kanda, H., Tateya, S., Tamori, Y., Kotani, K., Hiasa, K.-i., Kitazawa, R., Kitazawa, S., Miyachi, H., Maeda, S., Egashira, K. and Kasuga, M. (2006) MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity. J. Clin. Invest. 116, 1494-1505
12. Weisberg, S. P., Hunter, D., Huber, R., Lemieux, J., Slaymaker, S., Vaddi, K., Charo, I., Leibel, R. L. and Ferrante, Jr, A.W. (2006) CCR2 modulates inflammatory and metabolic effects of high-fat feeding. J. Clin. Invest. 116, 115-124
13. Westerbacka, J., Kolak, M., Kiviluoto, T., Arkkila, P., Siren, J., Hamsten, A., Fisher, R. M. and Yki-Jarvinen, H. (2007) Genes involved in fatty acid partitioning and binding, lipolysis, monocyte/macrophage recruitment, and inflammation are overexpressed in the human fatty liver of insulin-resistant subjects. Diabetes 56, 2759-2765
14. Bertola, A., Bonnafous, S., Anty, R., Patouraux, S., Saint-Paul, M. C., Iannelli, A., Gugenheim, J., Barr, J., Mato, J. M., Le Marchand-Brustel, Y. et al. (2010) Hepatic expression patterns of inflammatory and immune response genes associated with obesity and NASH in morbidly obese patients. PLoS ONE 5, e13577
15. Kassel, K. M., Guo, G. L., Tawfik, O. and Luyendyk, J. P. (2010) Monocyte chemoattractant protein-1 deficiency does not affect steatosis or inflammation in livers of mice fed a methionine-choline-deficient diet. Lab. Invest. 90, 1794-1804
16. Zamara, E., Galastri, S., Aleffi, S., Petrai, I., Aragno, M., Mastrocola, R., Novo, E., Bertolani, C., Milani, S., Vizzutti, F. et al. (2007) Prevention of severe toxic liver injury and oxidative stress in MCP-1-deficient mice. J. Hepatol. 46, 230-238
17. Vizzutti, F., Provenzano, A., Galastri, S., Milani, S., Delogu, W., Novo, E., Caligiuri, A., Zamara, E., Arena, U., Laffi, G. et al. (2010) Curcumin limits the fibrogenic evolution of experimental steatohepatitis. Lab. Invest. 90, 104-115
18. Novo, E., Busletta, C., Bonzo, L. V., Povero, D., Paternostro, C., Mareschi, K., Ferrero, I., David, E., Bertolani, C., Caligiuri, A. et al. (2011) Intracellular reactive oxygen species are required for directional migration of resident and bone marrow-derived hepatic pro-fibrogenic cells. J. Hepatol. 54, 964-974
19. Brun, P., Castagliuolo, I., Pinzani, M., Palu, G. and Martines, D. (2005) Exposure to bacterial cell wall products triggers an inflammatory phenotype in hepatic stellate cells. Am. J. Physiol. Gastrointest. Liver Physiol. 289, G571-G578
20. Leclercq, I. A., Farrell, G. C., Field, J., Bell, D. R., Gonzalez, F. J. and Robertson, G. R. (2000) CYP2E1 and CYP4A as microsomal catalysts of lipid peroxides in murine nonalcoholic steatohepatitis. J. Clin. Invest. 105, 1067-1075
21. Sahin, H., Trautwein, C. and Wasmuth, H. E. (2010) Functional role of chemokines in liver disease models. Nat. Rev. Gastroenterol. Hepatol. 7, 682-690
22. Haukeland, J.W., Damas, J. K., Konopski, Z., Loberg, E. M., Haaland, T., Goverud, I., Torjesen, P. A., Birkeland, K., Bjoro, K. and Aukrust, P. (2006) Systemic inflammation in nonalcoholic fatty liver disease is characterized by elevated levels of CCL2. J. Hepatol. 44, 1167-1174
23. Leclercq, I. A., Farrell, G. C., Sempoux, C., dela Pena, A. and Horsmans, Y. (2004) Curcumin inhibits NF-κB activation and reduces the severity of experimental steatohepatitis in mice. J. Hepatol. 41, 926-934
24. Feldstein, A. E. and Bailey, S. M. (2011) Emerging role of redox dysregulation in alcoholic and nonalcoholic fatty liver disease. Antioxid. Redox Signaling 15, 421-424
25. Sanyal, A. J., Chalasani, N., Kowdley, K. V., McCullough, A., Diehl, A. M., Bass, N. M., Neuschwander-Tetri, B. A., Lavine, J. E., Tonascia, J., Unalp, A. et al. (2010) Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis. N. Engl. J. Med. 362, 1675-1685
26. Shi, Z., Wakil, A. E. and Rockey, D. C. (1997) Strain-specific differences in mouse hepatic wound healing are mediated by divergent T helper cytokine responses. Proc. Natl. Acad. Sci. U.S.A. 94, 10663-10668
27. Marra, F., Aleffi, S., Galastri, S. and Provenzano, A. (2009) Mononuclear cells in liver fibrosis. Semin Immunopathol. 31, 345-358
28. Barron, L. and Wynn, T. A. (2011) Fibrosis is regulated by Th2 and Th17 responses and by dynamic interactions between fibroblasts and macrophages. Am. J. Physiol. Gastrointest. Liver Physiol. 300, G723-G728
29. Jin, Z., Sun, R., Wei, H., Gao, X., Chen, Y. and Tian, Z. (2011) Accelerated liver fibrosis in hepatitis B virus transgenic mice: involvement of natural killer T cells. Hepatology 53, 219-229
30. Aoudjehane, L., Pissaia, Jr, A., Scatton, O., Podevin, P., Massault, P. P., Chouzenoux, S., Soubrane, O., Calmus, Y. and Conti, F. (2008) Interleukin-4 induces the activation and collagen production of cultured human intrahepatic fibroblasts via the STAT-6 pathway. Lab. Invest. 88, 973-985
31. Laskin, D. L., Sunil, V. R., Gardner, C. R. and Laskin, J. D. (2010) Macrophages and tissue injury: agents of defense or destruction? Annu. Rev. Pharmacol. Toxicol. 51, 267-288
32. Sica, A. and Mantovani, A. (2012) Macrophage plasticity and polarization: in vivo veritas. J. Clin. Invest. 122, 787-795
33. Westcott, D. J., Delproposto, J. B., Geletka, L. M., Wang, T., Singer, K., Saltiel, A. R. and Lumeng, C. N. (2009) MGL1 promotes adipose tissue inflammation and insulin resistance by regulating 7/4hi monocytes in obesity. J. Exp. Med. 206, 3143-3156
34. Lomonaco, R., Ortiz-Lopez, C., Orsak, B., Finch, J., Webb, A., Bril, F., Louden, C., Tio, F. and Cusi, K. (2011) Role of ethnicity in overweight and obese subjects with nonalcoholic steatohepatitis (NASH). Hepatology 54, 837-845
35. Kruglov, E. A., Nathanson, R. A., Nguyen, T. and Dranoff, J. A. (2006) Secretion of MCP-1/CCL2 by bile duct epithelia induces myofibroblastic transdifferentiation of portal fibroblasts. Am. J. Physiol. Gastrointest. Liver Physiol. 290, G765-G771
36. Seki, E., de Minicis, S., Inokuchi, S., Taura, K., Miyai, K., van Rooijen, N., Schwabe, R. F. and Brenner, D. A. (2009) CCR2 promotes hepatic fibrosis in mice. Hepatology 50, 189-197
37. Baeck, C., Wehr, A., Karlmark, K. R., Heymann, F., Vucur, M., Gassler, N., Huss, S., Klussmann, S., Eulberg, D., Luedde, T. et al. (2012) Pharmacological inhibition of the chemokine CCL2 (MCP-1) diminishes liver macrophage infiltration and steatohepatitis in chronic hepatic injury. Gut 61, 416-426
38. Berres, M. L., Koenen, R. R., Rueland, A., Zaldivar, M. M., Heinrichs, D., Sahin, H., Schmitz, P., Streetz, K. L., Berg, T., Gassler, N. et al. (2010) Antagonism of the chemokine Ccl5 ameliorates experimental liver fibrosis in mice. J. Clin. Invest. 120, 4129-4140